GOLDAN KEITH A. (Chief Financial Officer) sold 1.4% of their position (1.30K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $12.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/18/2025ACC: 0000950170-25-096948
Officer· Chief Financial Officer
Since Jun 2022
-1.30K
Net shares
Net seller
$12.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.30K
Price / share
$9.29
Trade value
$12.03K
% of position
1.4%
7/16/2025
93.75K→92.45K
Total
Net shares
−1.30K
Net value
-$12.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2025 | S · Sale | −1.30K | $9.29 | $12.03K | 1.4% | 93.75K | 92.45K |
| Total | −1.30K | -$12.03K | ||||||
Derivative Transactions0
No derivative transactions reported